Omega Healthcare Investors (NYSE:OHI) Issues FY 2024 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 2.840-2.860 for the period, compared to the consensus estimate of 2.830. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

A number of research firms recently commented on OHI. Wells Fargo & Company reiterated an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a research note on Friday, October 18th. They issued a “buy” rating and a $45.00 target price for the company. BMO Capital Markets lifted their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. Truist Financial lifted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Finally, Scotiabank raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Eight investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $37.80.

Omega Healthcare Investors Price Performance

NYSE OHI traded up $0.68 on Wednesday, hitting $42.56. The company had a trading volume of 1,681,560 shares, compared to its average volume of 1,642,659. The company has a market capitalization of $10.97 billion, a PE ratio of 31.97, a PEG ratio of 1.34 and a beta of 1.00. The company’s fifty day moving average price is $40.25 and its 200-day moving average price is $35.79. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79. Omega Healthcare Investors has a 12-month low of $27.53 and a 12-month high of $42.67.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.20). The company had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. Omega Healthcare Investors’s revenue was up 17.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.74 EPS. As a group, analysts predict that Omega Healthcare Investors will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.30%. The ex-dividend date is Monday, November 4th. Omega Healthcare Investors’s payout ratio is presently 204.58%.

Insider Buying and Selling

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.